Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%) Natco Pharma receives FIPB approval to raise Foreign Investment Limit to 31.5%
Date: 14-08-2015Natco Pharma has received approval from Foreign Investment Promotion Board (FIPB) for increase of Foreign Investment Limit from 24% to 31.5% of the paid up equity share capital of the company. FIPB has also approved issue and allotment of eligible securities to Qualified Institutional Buyers (QIBs) up to Rs 450 crore.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.